LOINC Code 103565-8: HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA NAA+probe Ql (S/P/Bld donor)
103565-8 is a LOINC code used to identify HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA NAA+probe Ql (S/P/Bld donor) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA+Hepatitis E virus RNA. It is commonly used with the system or sample type Ser/Plas/Bld^Donor.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA+Hepatitis E virus RNA. It is commonly used with the system or sample type Ser/Plas/Bld^Donor.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Both
- Method: Probe.amp.tar
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection
- HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA+Hepatitis E virus RNA
- This term is created for but not restricted in use to the cobas® MPX-E test, which is FDA-approved qualitative in vitro nucleic acid screening test for human immunodeficiency virus type 1 (HIV-1) RNA (HIV-1 Group M & Group O RNA), HIV-2 RNA, hepatitis B virus (HBV) RNA, hepatitis C virus (HCV) RNA, hepatitis E virus (HEV) RNA in specimens from individual donors. This test is intended for determining the eligibility of donors and is not intended for clinical or diagnostic evaluation of patients.
- 3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; HBV; HCV; Hep; Hep B; Hep C; Hep E; Hepatis; Hepatit; HepB; HEV; HEV RNA; HIV type 1; HIV type 2; HIV type I; HIV type II; HIV1; HIV1,2+HCV+HBV+HEV; HIV1+HIV2+HCV+HBV; Human immunodeficiency virus; i; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.